NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









Septerna

Septerna

Public
South San Francisco, CaliforniaBiotechhttps://www.septerna.com

Last Round

IPO Announced

Oct 24, 2024

Est. Valuation

$799.25M

Total Funding Raised

$581.2M

Company Overview

Septerna is a biotechnology company that develops innovative small molecule medicines aimed at g-protein-coupled receptors, utilizing advanced drug discovery techniques to facilitate the identification of treatments for various diseases.

Sector

Biotech

AI Layer

Non-AI

Keywords

GPCR drug discovery platformoral small molecule GPCR therapeuticsundruggable G protein-coupled receptor (GPCR) targetsproprietary GPCR stabilization technologytherapeutics for endocrinology and metabolic disordersbiotech drug development and licensingincretin receptor agonist for obesityPTH1R agonist for hypoparathyroidismclinical-stage biotechnology companyMRGPRX2 negative allosteric modulator (NAM)therapeutics for mast cell-driven diseasesTSHR negative allosteric modulator (NAM) for Graves' disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Septerna Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Septerna Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
IPO AnnouncedOct 24, 2024
Series BJul 11, 2023
Series AJan 27, 2022

Septerna Investors

Notable investors and investment history

Septerna Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Septerna Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range129
Year Founded2020
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.